Cargando…

An elevated monocyte-to-high-density lipoprotein–cholesterol ratio is associated with mortality in patients with coronary artery disease who have undergone PCI

Background: The aim of the present study was to investigate the association between the monocyte-to-high-density lipoprotein–cholesterol ratio (MHR) and the outcomes of patients with coronary artery disease (CAD) who were treated with percutaneous coronary intervention (PCI). Methods: A total of 567...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Da-Peng, Baituola, Gulinaer, Wu, Ting-Ting, Chen, You, Hou, Xian-Geng, Yang, Yi, Pan, Ying, Ma, Xiang, Zheng, Ying-Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Portland Press Ltd. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7432996/
https://www.ncbi.nlm.nih.gov/pubmed/32766711
http://dx.doi.org/10.1042/BSR20201108
_version_ 1783571920126476288
author Zhang, Da-Peng
Baituola, Gulinaer
Wu, Ting-Ting
Chen, You
Hou, Xian-Geng
Yang, Yi
Pan, Ying
Ma, Xiang
Zheng, Ying-Ying
author_facet Zhang, Da-Peng
Baituola, Gulinaer
Wu, Ting-Ting
Chen, You
Hou, Xian-Geng
Yang, Yi
Pan, Ying
Ma, Xiang
Zheng, Ying-Ying
author_sort Zhang, Da-Peng
collection PubMed
description Background: The aim of the present study was to investigate the association between the monocyte-to-high-density lipoprotein–cholesterol ratio (MHR) and the outcomes of patients with coronary artery disease (CAD) who were treated with percutaneous coronary intervention (PCI). Methods: A total of 5679 CAD patients from CORFCHD-PCI, a retrospective cohort study (identifier: ChiCTR-ORC-16010153), who underwent PCI were included in the study and divided into three tertiles according to their MHR values. The primary outcome was long-term mortality after PCI. The main secondary endpoints were stroke, readmission, and major adverse cardiovascular events (MACEs), defined as the combination of cardiac death, recurrent myocardial infarction, and target vessel reconstruction. The average follow-up time was 35.9 ± 22.6 months. Results: Patients were divided into three groups according to MHR tertiles: the first tertile (MHR < 0.4; n=1290), second tertile (MHR ≥ 0.4–0.61; n=1878) and third tertile (MHR > 0.61; n=1870). The all-cause mortality (ACM) incidence was significantly lower in the first and second tertiles than in the third tertile (adjusted HR = 0.658, [95% CI: 0.408–0.903], P=0.009 and HR = 0.712, [95% CI: 0.538–0.941], P=0.017, respectively). Cardiac mortality (CM) occurred in 235 patients: 60 (3.1%) in the first tertile group, 74 (3.9%) in the second tertile group and 101 (5.4%) in the third tertile group. There was a significant difference in the CM incidence between the first tertile group and the third tertile group (HR = 0.581, [95% CI: 0.406–0.832], P=0.003), and there was also a difference in the CM incidence between the second tertile group and the third tertile group (HR = 0.690, [95% CI: 0.506–0.940], P=0.019). Conclusion: The present study indicated that an increased MHR was independently associated with long-term mortality in CAD patients who have undergone PCI.
format Online
Article
Text
id pubmed-7432996
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Portland Press Ltd.
record_format MEDLINE/PubMed
spelling pubmed-74329962020-08-21 An elevated monocyte-to-high-density lipoprotein–cholesterol ratio is associated with mortality in patients with coronary artery disease who have undergone PCI Zhang, Da-Peng Baituola, Gulinaer Wu, Ting-Ting Chen, You Hou, Xian-Geng Yang, Yi Pan, Ying Ma, Xiang Zheng, Ying-Ying Biosci Rep Aging Background: The aim of the present study was to investigate the association between the monocyte-to-high-density lipoprotein–cholesterol ratio (MHR) and the outcomes of patients with coronary artery disease (CAD) who were treated with percutaneous coronary intervention (PCI). Methods: A total of 5679 CAD patients from CORFCHD-PCI, a retrospective cohort study (identifier: ChiCTR-ORC-16010153), who underwent PCI were included in the study and divided into three tertiles according to their MHR values. The primary outcome was long-term mortality after PCI. The main secondary endpoints were stroke, readmission, and major adverse cardiovascular events (MACEs), defined as the combination of cardiac death, recurrent myocardial infarction, and target vessel reconstruction. The average follow-up time was 35.9 ± 22.6 months. Results: Patients were divided into three groups according to MHR tertiles: the first tertile (MHR < 0.4; n=1290), second tertile (MHR ≥ 0.4–0.61; n=1878) and third tertile (MHR > 0.61; n=1870). The all-cause mortality (ACM) incidence was significantly lower in the first and second tertiles than in the third tertile (adjusted HR = 0.658, [95% CI: 0.408–0.903], P=0.009 and HR = 0.712, [95% CI: 0.538–0.941], P=0.017, respectively). Cardiac mortality (CM) occurred in 235 patients: 60 (3.1%) in the first tertile group, 74 (3.9%) in the second tertile group and 101 (5.4%) in the third tertile group. There was a significant difference in the CM incidence between the first tertile group and the third tertile group (HR = 0.581, [95% CI: 0.406–0.832], P=0.003), and there was also a difference in the CM incidence between the second tertile group and the third tertile group (HR = 0.690, [95% CI: 0.506–0.940], P=0.019). Conclusion: The present study indicated that an increased MHR was independently associated with long-term mortality in CAD patients who have undergone PCI. Portland Press Ltd. 2020-08-17 /pmc/articles/PMC7432996/ /pubmed/32766711 http://dx.doi.org/10.1042/BSR20201108 Text en © 2020 The Author(s). https://creativecommons.org/licenses/by/4.0/ This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution License 4.0 (CC BY).
spellingShingle Aging
Zhang, Da-Peng
Baituola, Gulinaer
Wu, Ting-Ting
Chen, You
Hou, Xian-Geng
Yang, Yi
Pan, Ying
Ma, Xiang
Zheng, Ying-Ying
An elevated monocyte-to-high-density lipoprotein–cholesterol ratio is associated with mortality in patients with coronary artery disease who have undergone PCI
title An elevated monocyte-to-high-density lipoprotein–cholesterol ratio is associated with mortality in patients with coronary artery disease who have undergone PCI
title_full An elevated monocyte-to-high-density lipoprotein–cholesterol ratio is associated with mortality in patients with coronary artery disease who have undergone PCI
title_fullStr An elevated monocyte-to-high-density lipoprotein–cholesterol ratio is associated with mortality in patients with coronary artery disease who have undergone PCI
title_full_unstemmed An elevated monocyte-to-high-density lipoprotein–cholesterol ratio is associated with mortality in patients with coronary artery disease who have undergone PCI
title_short An elevated monocyte-to-high-density lipoprotein–cholesterol ratio is associated with mortality in patients with coronary artery disease who have undergone PCI
title_sort elevated monocyte-to-high-density lipoprotein–cholesterol ratio is associated with mortality in patients with coronary artery disease who have undergone pci
topic Aging
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7432996/
https://www.ncbi.nlm.nih.gov/pubmed/32766711
http://dx.doi.org/10.1042/BSR20201108
work_keys_str_mv AT zhangdapeng anelevatedmonocytetohighdensitylipoproteincholesterolratioisassociatedwithmortalityinpatientswithcoronaryarterydiseasewhohaveundergonepci
AT baituolagulinaer anelevatedmonocytetohighdensitylipoproteincholesterolratioisassociatedwithmortalityinpatientswithcoronaryarterydiseasewhohaveundergonepci
AT wutingting anelevatedmonocytetohighdensitylipoproteincholesterolratioisassociatedwithmortalityinpatientswithcoronaryarterydiseasewhohaveundergonepci
AT chenyou anelevatedmonocytetohighdensitylipoproteincholesterolratioisassociatedwithmortalityinpatientswithcoronaryarterydiseasewhohaveundergonepci
AT houxiangeng anelevatedmonocytetohighdensitylipoproteincholesterolratioisassociatedwithmortalityinpatientswithcoronaryarterydiseasewhohaveundergonepci
AT yangyi anelevatedmonocytetohighdensitylipoproteincholesterolratioisassociatedwithmortalityinpatientswithcoronaryarterydiseasewhohaveundergonepci
AT panying anelevatedmonocytetohighdensitylipoproteincholesterolratioisassociatedwithmortalityinpatientswithcoronaryarterydiseasewhohaveundergonepci
AT maxiang anelevatedmonocytetohighdensitylipoproteincholesterolratioisassociatedwithmortalityinpatientswithcoronaryarterydiseasewhohaveundergonepci
AT zhengyingying anelevatedmonocytetohighdensitylipoproteincholesterolratioisassociatedwithmortalityinpatientswithcoronaryarterydiseasewhohaveundergonepci
AT zhangdapeng elevatedmonocytetohighdensitylipoproteincholesterolratioisassociatedwithmortalityinpatientswithcoronaryarterydiseasewhohaveundergonepci
AT baituolagulinaer elevatedmonocytetohighdensitylipoproteincholesterolratioisassociatedwithmortalityinpatientswithcoronaryarterydiseasewhohaveundergonepci
AT wutingting elevatedmonocytetohighdensitylipoproteincholesterolratioisassociatedwithmortalityinpatientswithcoronaryarterydiseasewhohaveundergonepci
AT chenyou elevatedmonocytetohighdensitylipoproteincholesterolratioisassociatedwithmortalityinpatientswithcoronaryarterydiseasewhohaveundergonepci
AT houxiangeng elevatedmonocytetohighdensitylipoproteincholesterolratioisassociatedwithmortalityinpatientswithcoronaryarterydiseasewhohaveundergonepci
AT yangyi elevatedmonocytetohighdensitylipoproteincholesterolratioisassociatedwithmortalityinpatientswithcoronaryarterydiseasewhohaveundergonepci
AT panying elevatedmonocytetohighdensitylipoproteincholesterolratioisassociatedwithmortalityinpatientswithcoronaryarterydiseasewhohaveundergonepci
AT maxiang elevatedmonocytetohighdensitylipoproteincholesterolratioisassociatedwithmortalityinpatientswithcoronaryarterydiseasewhohaveundergonepci
AT zhengyingying elevatedmonocytetohighdensitylipoproteincholesterolratioisassociatedwithmortalityinpatientswithcoronaryarterydiseasewhohaveundergonepci